MCB(MCB)
MCB
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $379M | $434M | $505M |
| Low | $378M | $433M | $504M |
| High | $380M | $435M | $506M |
| EBITDA Avg | $112M | $128M | $150M |
| Low | $112M | $128M | $149M |
| High | $112M | $129M | $150M |
| EBIT Avg | $110M | $126M | $146M |
| Low | $109M | $125M | $146M |
| High | $110M | $126M | $147M |
| Net Income Avg | $102M | $123M | $156M |
| Low | $102M | $122M | $155M |
| High | $103M | $123M | $156M |
| EPS Avg | $9.53 | $11.41 | $14.50 |
| Low | $9.51 | $11.38 | $14.46 |
| High | $9.56 | $11.44 | $14.54 |
| Analysts (Rev / EPS) | 2 / 2 | 2 / 2 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $97M | $101M | $102M | $106M | $111M | $115M |
| Low | $96M | $100M | $101M | $106M | $110M | $114M |
| High | $98M | $101M | $102M | $107M | $112M | $115M |
| EBITDA Avg | $29M | $30M | $30M | $32M | $33M | $34M |
| Low | $29M | $30M | $30M | $31M | $33M | $34M |
| High | $29M | $30M | $30M | $32M | $33M | $34M |
| EBIT Avg | $28M | $29M | $29M | $31M | $32M | $33M |
| Low | $28M | $29M | $29M | $31M | $32M | $33M |
| High | $28M | $29M | $30M | $31M | $32M | $33M |
| Net Income Avg | $27M | $29M | $30M | $32M | $34M | $36M |
| Low | $26M | $29M | $29M | $32M | $34M | $36M |
| High | $28M | $30M | $30M | $32M | $34M | $36M |
| EPS Avg | $2.36 | $2.56 | $2.57 | $2.77 | $2.96 | $3.11 |
| Low | $2.28 | $2.49 | $2.55 | $2.74 | $2.94 | $3.08 |
| High | $2.46 | $2.63 | $2.59 | $2.79 | $2.99 | $3.13 |
| Analysts (Rev / EPS) | 3 / 3 | 3 / 3 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |